Acrx Stock Forecast Zacks

Free stock analysis report to read this article on. Free stock analysis report to read this article on.

Motley Fool Vs Zacks - Which Is Better Side By Side Comparison 2021

Today, you can download 7 best stocks for the next 30 days.

Acrx stock forecast zacks. Click to get this free report acelrx pharmaceuticals, inc. Today, you can download 7 best stocks for the next 30 days. Acelrx pharmaceuticals (acrx) could be a solid choice for investors given its recent upgrade to a zacks rank #2 (buy).

Click to get this free report acelrx pharmaceuticals, inc. Acelrx pharmaceuticals (acrx) may report negative earnings: By zacks equity research published on november 05,2020.

Read more on zacks share this post Analyst price target on acrx. This compares to loss of $0.18 per share a year ago.

Today, you can download 7 best stocks for the next 30 days. On the other hand, the stock currently carries a zacks rank of #4. Is currently rated as a zacks rank 4 and we are expecting a below average return from the.

Free stock analysis report to read this article on. Click to get this free report acelrx pharmaceuticals, inc. Acrx | complete acelrx pharmaceuticals inc.

1 wall street analysts that have issued a 1 year acrx price target, the average acrx price target is $5.00, with the highest acrx stock price forecast at $5.00 and the lowest acrx stock price forecast at $5.00. Acelrx pharmaceuticals stock forecast by wall street analysts. Based on 1 wall street analysts offering 12 month price targets for acelrx in the last 3 months.

The average price target represents a 350.45% change from the last price of $1.11. The zacks rating relies solely on a company's changing earnings picture. Click to get this free report acelrx pharmaceuticals, inc.

The average price target is $5.00 with a high forecast of $5.00 and a low forecast of $5.00. The highest, average, and lowest price. Free stock analysis report to read this article on zacks.com click here.

Since then, acrx stock has decreased by 46.5% and is now trading at $0.6522. This compares to loss of $0.08 per share a. Acelrx pharmaceuticals (acrx) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its.

Acelrx pharmaceuticals (acrx) came out with a quarterly loss of $0.10 per share versus the zacks consensus estimate of a loss of $0.12. Zacks' proprietary data indicates that acelrx pharmaceuticals, inc. Acelrx pharmaceuticals (acrx) reports q3 loss, misses revenue estimates.

Strong buy stocks for december, 2021. Acelrx pharmaceuticals (acrx) delivered earnings and. According to the issued ratings of 1 analysts in the last year, the consensus rating for acelrx pharmaceuticals stock is buy based on the current 1 buy rating for acrx.

So, this combination makes it difficult to conclusively predict that acelrx pharmaceuticals will. View acelrx pharmaceuticals acrx investment & stock information. Acelrx pharmaceuticals (acrx) came out with a quarterly loss of $0.08 per share in line with the zacks consensus estimate.